FGL1 was found to be over‐expressed in human liver cancer as a major ligand of Lag‐3 which is responsible for its T‐cell inhibitory function, and had a link with a poor prognosis and therapeutic outcome.18, 19, 20. This evidence concerns the gene LAG3 and liver cancer.